RxPonder
RxPonder Changes the Field for Premenopausal Breast Cancer Patients With Involved Nodes
Attention must be paid to this large study that showed a substantial 5-year benefit from adding chemotherapy to the ...
FEBRUARY 25, 2021
RxPonder Results for Postmenopausal Women: Skip Chemo With RS <26 and 1 to 3 Positive Nodes
RxPonder is not a noninferiority study showing that we lose very little by skipping chemotherapy for postmenopausal ...
FEBRUARY 25, 2021
Load more